Sanjay Subramanian

Companies

• SCYNEXIS INCChief financial officer Sep 11, 2026 to now¹
• Inozyme Pharma, Inc.Chief financial officer Mar 22, 2022 to now²
• OcugenChief financial officer Oct 4, 2019 to Jan 5, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Ocugen OCGN161,125 shares⁴$131.2K at $0.81Jan 3, 2022
• IPInozyme Pharma, Inc.0 shares⁵Jul 1, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2025U 39,701 shares at $4.00 of Inozyme Pharma, Inc.⁵
• Jun 25, 2025Granted 6,813 shares at $0.74 of Inozyme Pharma, Inc.⁶
• Mar 31, 2025Granted 2,490 shares at $0.77 of Inozyme Pharma, Inc.⁷
• Sep 29, 2023Granted 2,319 shares at $3.57 of Inozyme Pharma, Inc.⁸
• Mar 31, 2023Granted 979 shares at $2.21 of Inozyme Pharma, Inc.⁹
• Apr 19, 2022Bought 27,100 shares at $3.69 of Inozyme Pharma, Inc.¹⁰
• Jan 3, 2022Granted 125,534 shares of Ocugen⁴
• Oct 26, 2021Sold 10,000 shares at $11.07 of Ocugen¹¹
• Oct 15, 2021Sold 7,990 shares at $9.96 of Ocugen¹²
• Oct 15, 2021Exercised options 7,990 shares at $2.19 of Ocugen¹²